Earlier studies have suggested increased central norepinephrine, serotonin synthesis, atrial natriuretic peptide, and beta-endorphins serve as biological mediators for a possible therapeutic effect in depression [23,29-30]. The gene discussed is POMC; the disease is depressive symptom measurement.